RecruitingNCT06904677

Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer

Predicting and Evaluating the Efficacy of Neoadjuvant Therapy in Colorectal Cancer Based on 4D Deep Urinary Proteomics Technology


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

400 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn how well urinary proteins can predict treatment response in patients with locally advanced colorectal cancer (LACC) undergoing neoadjuvant therapy. The main question it aims to answer is: Can urinary protein markers help predict and evaluate how patients with LACC respond to neoadjuvant therapy? Participants diagnosed with LACC will provide urine samples before and after neoadjuvant therapy. These samples will be analyzed using 4D deep urinary proteomics and machine learning to identify proteins linked to treatment response. Some participants' tumor tissues will also be used to create organoid models for further testing.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether proteins found in urine can predict how well colorectal cancer will respond to chemotherapy and other treatments before surgery — which could help doctors personalize treatment plans. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with locally advanced colorectal cancer (cancer that has grown into nearby tissue or lymph nodes) confirmed by biopsy - Your cancer has not spread to distant organs - You are planned to receive chemotherapy or other treatment before surgery (neoadjuvant therapy) - You have not had any prior targeted therapy or immunotherapy - You are willing to provide urine samples at specific timepoints **You may NOT be eligible if...** - You have a history of other cancers - You have serious kidney, liver, heart, or metabolic problems that could affect urine protein levels - Your cancer has already spread to other organs Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Chaoyang District, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06904677


Related Trials